| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |